| Biomarker ID | 1030 |
| PMID | 23231923 |
| Year | 2012 |
| Biomarker | miR-30d |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in PCa [Normal (6.23 ± 6.06) Vs Cancer (7.95 ± 7.03)] |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- transcription by RNA polymerase II; regulation of transcription by RNA polymerase II; Gene expression (Transcription); cellular protein modification process; protein modification process |
| Experiment | Cancerous Vs Cancer Adjacent from Same patient |
| Type of Biomarker | Diagnostic |
| Cohort | surgical specimens obtained during radical prostatectomy (n = 56) along with paired normal controls from the same patients |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p = 0.03 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | miR-30d |